Focus Stocks
Trading Boston Beer
Published on Thursday, 09 February 2012 07:16 Written by TradersHuddle Wire
New York, February 9th (TradersHuddle.com) - Shares of Boston Beer Company, Inc. (NYSE:SAM) closed the trading session at $102.74 near its 50 day moving average currently set at $102.82. Boston Beer's price action is below this important level, which makes the stock difficult to buy, as there will certainly be resistance as it approaches its 50 day.
The Boston Beer Company, Inc. (NYSE:SAM) produces a variety of craft-brewed beers at various contract breweries and Company-owned breweries. The Company sells its products under brand names such as Boston Beer Company, Oregon Beer and Samuel Adams.
Latest price action range, defined by a peaks and troughs algorithm places calculated support at $98.62 and calculated resistance at $108.16. These levels will be closely watched by traders, as they provide great insight into the latest price dynamics defined by Boston Beer shares.
Traders should evaluate their trade if they want to establish a position on Boston Beer given the resistance expected as the stock approaches the 50 day moving average. A trade might materialize as the stock manages to break this important level, as it could be used as support going forward, however until the break materializes buying the stock is nothing different than flipping a coin. Other levels that traders will be evaluating are the ones defined by the peak and troughs algorithm that provides great price level reference points.
Related Articles
- Boston Beer Is Close to the 50 Day Moving Average
- Boston Beer Is Near a Key Resistance Area
- Above Resistance: Boston Beer
- Boston Beer Reports First Quarter 2012 Results
- Boston Beer Is Near a Key Resistance Area
- Boston Beer Is Approaching its 50 Day Moving Average
- Boston Beer near Support
- New Analyst Coverage
- Is Boston Beer Expecting Resistance Soon?
- Reference Points for Boston Beer
Related Partner Headlines
- UPDATE: Jefferies Raises PT to $103 on Boston Beer Company; Strong Volume - Benzinga
- Boston Beer Tops Street Estimates - Benzinga
- Boston Beer Company Inc. (SAM): Today's Featured Food & Beverage Winner - TheStreet.com
- 3 Things You Should Know About Small Business: April 24 - TheStreet.com
- Raise a Glass With SAM - TheStreet.com
- Sierra Nevada CEO Makes East Coast Beer Run - TheStreet.com
- UPDATE: Deutsche Bank Raises Target on Boston Beer Company to $97 - Benzinga
- The Boston Beer Company Reports Strong Q4 Results - Benzinga
- 5 Champagne Beers For New Year's Toasting - TheStreet.com
- Boston Beer Stock Hits New 52-Week High (SAM) - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Recent Trading Ideas
Latest Partner Headlines
-
The Dow Bounces on Test of 12,312 - TheStreet.com -
Coming Week: Top Nine Earnings on Deck - TheStreet.com -
For Ambitious Students, Entrepreneurship Can Be a Big Win - TheStreet.com -
Something's Not Right in the Video-Game Space - TheStreet.com -
Stock Futures Rise on Eurobond Talk - TheStreet.com -
You Can Let Your Guard Down: Ask Noah - TheStreet.com -
NYSE Is Winning the IPO Listing War - TheStreet.com -
Apple Strengthens Its Supply Chain - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis -
SunOpta Enters Into Agreement to Divest Its Canadian Based Natural Health Products Business -
PC Connection, Inc. (PCCC) To Present at The SeeThruEquity First Annual Small Cap Investor Conference on Tuesday, June 5, 2012 -
Aeroflex Announces Amendment to Credit Agreement -
Alliance Data to Participate at Upcoming Investor Conferences -
PCA3 Test Featured at American Urological Association Meeting -
MOCON Announces Quarterly Dividend -
Government of Rwanda Introduces Merck's ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus









